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Chronic rhinosinusitis (CRS) affects approximately 5% of the adult population in Western
societies and severely reduces the patient’s quality of life. The role of bacteria in the
pathogenesis of this condition has not yet been established with certainty. However,
recent reports of bacterial and fungal bioﬁlms in CRS highlight a potential role for these
microorganisms. In this study, 16S rRNA gene-targeted amplicon pyrosequencing and
qPCR were used to determine the composition and abundance, respectively, of the sinus
microbiota within 9 patients with CRS and 6 healthy individuals. Within-patient variability
was also investigated by sampling fromanterior nares, inferior turbinate, andmiddlemeatus
on each side of the sinuses. Our results indicate that more of the variation in bacterial
composition can be explained by inter-personal differences, rather than sampling location
or even disease status. In addition, bacterial community diversity was signiﬁcantly lower
in CRS samples compared to those from healthy subjects, whereas bacterial load was not
associated with disease status. Although members of the genera Corynebacterium and
Staphylococcus were prevalent in the majority of samples (including healthy subjects), the
large amount of variation observed between individuals, particularly within the CRS cohort,
suggests that an imbalance or dysbiosis in community structure could be the driving force
behind the disease. Ultimately, understanding the causes of variation within the sinus
microbiota may lead to more personalized treatment options for CRS.
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INTRODUCTION
Chronic rhinosinusitis (CRS) is a persistent inﬂammatory condi-
tionof thenasal passages and theparanasal sinuses (Bhattacharyya,
2009; Soler et al., 2011). It affects approximately 5% of the West-
ern population (Fokkens et al., 2012) and in the USA alone is
responsible for an estimated $8.6 billion per annum in direct
medical expenditures (Ray et al., 1999; Bhattacharyya, 2003). CRS
results in signiﬁcant morbidity in young and middle-aged adults,
impacting substantially upon quality of life (Gliklich and Metson,
1995). Although antibiotics are used frequently in its treatment,
the role of bacteria in the pathogenesis of this condition remains
far from clear.
The role of changes in the nasal microbiota in the patho-
genesis of CRS has come under increasing scrutiny, with a
number of recent studies comparing the composition of bac-
teria in CRS patients vs. healthy subjects (Abreu et al., 2012;
Feazel et al., 2012; Aurora et al., 2013; Boase et al., 2013).
These studies, which have employed cultivation-independent
(molecular) approaches to investigate the diversity of bacte-
ria among samples, have yielded a range of results without a
strongly emergent pattern. For example, the study of Abreu et al.
(2012) utilized a 16S rRNA gene-targeting PhyloChip (diagnostic
microarray; Brodie et al., 2006) to evaluate microbial commu-
nity composition in CRS-affected and healthy individuals. The
PhyloChip data implicated the bacterium Corynebacterium tuber-
culostearicum as a potential causative agent of CRS, particularly
in conjunction with perturbation of the sinus microbiota. Impor-
tantly, this ﬁnding was supported by subsequent murine model
experiments (Abreu et al., 2012). Other recent studies have
linked CRS with changes in Staphylococcus aureus abundance
or activity, decreased Prevotella spp., increased Corynebacterium
accolens, lower microbial diversity, and increased microbial abun-
dance, with no apparent consensus between individual studies
(Feazel et al., 2012; Foreman et al., 2012; Boase et al., 2013;
Ramakrishnan et al., 2013a; Choi et al., 2014; Cleland et al.,
2014).
Considering the results of these recent studies, it is evident
that the relationship between CRS and the sinus microbiota
is complicated. The heterogeneous nature of the microbial
association with CRS is highlighted by the marked differences
in reported microbial communities between various studies,
between phenotypic (polyps or without polyps; Fokkens et al.,
2012) and immunological or histological subgroups of CRS
(eosinophilic or neutrophilic; Kountakis et al., 2004; De Alar-
cón et al., 2006; Park et al., 2013; Bochenek et al., 2014) and
the varying responses of patients to antibiotic and corticosteroid
treatment (Joe et al., 2008; Liu et al., 2013). The causes of such
variation are poorly understood, but could include differences
among populations of patients (e.g., antibiotic history, ethnicity),
methodology, genetics, environmental factors or simply natu-
ral variation among different parts of the nasal passages and
sinuses.
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Relatively few studies have investigated the impact of spatial
variability in the microbiota of the human nasal cavity. One recent
study found that epithelium type in healthy nasal passages has a
signiﬁcant impact on bacterial community diversity (Yan et al.,
2013), with no distinct patterns in bacterial composition between
sites. Another study demonstrated that the nasal microbiome is
distinctly different to that of the oral and buccal cavity within an
individual (Bassis et al., 2014). As both of these studies were con-
ducted on healthy people, the impact of spatial variability in the
nasal cavity of CRS patients is still not understood, let alone the
extent of variation between different patients. It is a fundamental
goal within microbial ecology to describe spatial variability in bac-
terial communities (Hanson et al., 2012), yet the clinical relevance
of such research should also not be overlooked. Topical applica-
tion of antibiotics or steroids, or even the addition of probiotic
bacteria (Liu et al., 2013; Cleland et al., 2014), can be guided by
knowledge of variation in bacterial composition and load within
different parts of the nasal cavity. In short, an improved under-
standing of where and how the nasal microbiota varies should
lead to improved, more personalized treatment options in the
future.
In this study we used amplicon pyrosequencing and real-time
PCR of the 16S rRNA gene to describe the composition and abun-
dance of bacteria in subjects with and without CRS. Unlike many
previous studies, we do not groupCRS patients together but rather
explore the differences in bacterial communities between each
patient. Furthermore, we rigorously characterize within-subject
variability in the nasal microbiota, with analysis of six samples per
subject enabling novel insights into the spatial variation of these
bacteria.
MATERIALS AND METHODS
PATIENT INFORMATION
Fifteen patients (nine CRS and six non-CRS controls) undergo-
ing endoscopic sinus surgery were recruited for this study. The
control group were undergoing pituitary tumor resection surgery.
The CRS patients were chosen based on a Lund-Mackay score of
>10/24 and the results of CT scans. Patient information is pro-
vided in Table 1. Written consent from the patients and ethical
approval (NTX/08/12/126/AM01) from the New Zealand Health
and Disability Ethics Committee, was obtained for this study.
SAMPLE COLLECTION
Surgery was performed on patients under general anesthetic.
Sampling was performed immediately after induction prior to
the application of any topical mucosal preparation or delivery
of intravenous antibiotics. Sterile rayon-tipped swabs (Copan,
#170KS01) were used under endoscopic guidance to sample the
surface mucosa from each of three sites within the left and right
sides of the nostril: anterior nares, inferior turbinate, and middle
meatus. Duplicate swabs were taken from each of the six sites per
patient, thus a total of 12 swabs obtained for each individual. Swabs
were discarded and retaken if contaminated by mucosa outside the
target region. Immediately after collection, the tip of each swabwas
removed aseptically and placed in a sterile 1.5 mL polypropylene
tube on ice. Swabswere transported to the laboratory on ice within
2 h and stored at −20◦C until further analysis.
DNA EXTRACTION
Two replicate swabs from each of the six sites were thawed on
ice and placed together into a sterile Lysing Matrix E tube (MP
Biomedicals, Australia). Genomic DNA was extracted from the
samples using the AllPrep DNA/RNA Isolation Kit (Qiagen) fol-
lowing the manufacturer’s instructions and eluted in 30 μL of
DNase-free water. Cells were ruptured using a Qiagen TissueL-
yser II at 25 m/s for 2 × 40 s. The quality and quantity of genomic
DNA were measured on a Nanodrop 3300 ﬂuorospectrometer and
by using PicoGreen (Quant-iT dsDNA kit, Invitrogen) dye.
16S rRNA GENE AMPLICON PYROSEQUENCING
Bacterial 16S rRNA gene fragments from the extracted genomic
DNA were ampliﬁed using primers 347f and 803r, which have
been used previously to characterize the bacterial community
of the human foregut (Nossa et al., 2010). The applicability
of these primers to sinus microbial communities was vali-
dated in silico by using Probe Match in the RDP database
and SILVA databases. Sample preparation for amplicon pyrose-
quencing was as described previously (Biswas et al., 2014), with
some minor modiﬁcations. In brief, the aforementioned 16S
rRNA gene-targeting primers, complete with pyrosequencing
adaptors and unique multiplex identiﬁers (MIDs) on the for-
ward primer, were used in equimolar concentrations (0.2 μM)
together with dNTPs (0.2 mM), PCR buffer (1X), MgSO4
(2 mM), 0.5U Platinum Hi-ﬁdelity Taq (Invitrogen) and PCR-
certiﬁed water to a ﬁnal volume of 25 μL. PCR ampliﬁcation
was performed in an Applied Biosystems Mastercycle gradi-
ent PCR machine with an initial denaturing step of 94◦C
for 3 min, followed by 35 cycles of denaturation (94◦C for
30 s), annealing (55◦C for 30 s), and elongation (70◦C for
40 s), with a ﬁnal elongation step at 70◦C for 3 min. Ampli-
ﬁed products were puriﬁed using Agencourt AMPure beads
(Beckman Coulter Inc.), quantiﬁed using Picogreen, and qual-
itatively checked on Agilent 1200 Bioanalyzer DNA 1000 chips
(Agilent Technologies, Santa Clara, CA, USA). A nested-
PCR approach, using primers 616V (Spring et al., 1998) and
1492R (Polz and Cavanaugh, 1998) for the initial ampliﬁca-
tion, was adopted for the samples of two CRS patient sam-
ples (2 and 3), as the original PCR did not yield any prod-
ucts.
Equimolar concentrations of 36 prepared amplicon sam-
ples were pooled into a single library in accordance with the
instructions of Macrogen Inc. (Seoul, South Korea). Each
amplicon library (three were required in total to analyze all
90 samples) was sequenced on 1/8 plate of the Roche GS
FLX Titanium platform by Macrogen. Analysis of obtained
pyrosequencing reads was carried out as described previously
(Schmitt et al., 2012; Biswas et al., 2014). Brieﬂy, a com-
bination of mothur (Schloss et al., 2009) and custom-made
PERL scripts was used to retain only high-quality useable
reads that were aligned against the SILVA reference database
(http://www.mothur.org/wiki/Silva_reference_alignment). Oper-
ational taxonomic units (OTUs) were assigned at 97% similarity
based on an uncorrected pairwise distance matrix. A repre-
sentative sequence from each OTU was subjected to taxonomic
assignment using BLAST (Altschul et al., 1990) against a manually
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Table 1 | Patient information.
Patient No. Age Ethnicity Sex Diagnosis Asthma Smoker Prednisone* Antibiotics* L–M
1 46 NZE M CRS Y N Y N 11
2 43 NZE M CRS N N N N 15
3 51 NZE F CRS Y N Y N 20
4 48 NZE M CRS Y N N N 16
5 21 NZE M CRS, CF N N N N 21
6 27 Chile F CRS, polyposis Y N N N 14
7 69 other Euro M CRS Y N N N 15
8 39 Russian M CRS Y/N Y Y Y (Amoxicillin) 13
9 39 NZE M CRS, polyposis N N N N 13
Patient No. Age Ethnicity Sex Diagnosis Asthma Smoker Prednisone* Antibiotics* L–M
1 53 NZE M Healthy N N N N NA
2 80 NZE M Healthy N N N N NA
3 65 other M Healthy N Y N N NA
4 46 NZ Maori F Healthy N Y N N NA
5 23 NZ Maori F Healthy N N N N NA
6 31 Indian M Healthy N N N N NA
NZE, New Zealand European; N, No; Y, Yes; CF, Cystic ﬁbrosis; L –M, Lund–Mackay scale; Other, Asian ethnicity; Other Euro, Other European ethnicity. *Intake of
Prednisone or antibiotics 4 weeks prior to surgery.
curated SILVA database (Version 108) using custom-made PERL
scripts.
Multidimensional scaling (MDS) plots were constructed using
Primer 6 software (version 6.1.6) of the 16S rRNA gene-based
bacterial community composition at bacterial genus level. Bray–
Curtis similarity was chosen as the measure between samples on
the MDS plot.
REAL-TIME PCR
The volume of sample obtained was variable across each site.
Thus, to standardize the samples for quantiﬁcation purposes
across this study the relative proportions of human and bac-
terial DNA in the genomic extract was determined. For this
purpose, human beta-actin genes were quantiﬁed using the previ-
ously described primers bactin-F (nucleotide position, 393–413)
and bactin-R (622–642; Wang and Seed, 2003) targeting the
ACTB gene. To quantify bacterial 16S rRNA gene abundance
from extracted genomic DNA, we performed real-time PCR with
primers 8F and 341R (Juck et al., 2000; Kim et al., 2009). Total
numbers of 16S rRNA gene copies were calculated on the basis
of the proportion of bacterial DNA for each extraction. Stan-
dards were prepared from clone libraries of bacterial 16S rRNA
genes and from human genomic DNA (Promega) for ACTB. A
10-fold dilution series for each gene of interest was prepared (10–
100,000 target copies per reaction for bacteria; 0.01–100 ng/μL
for human DNA). Ampliﬁcation efﬁciency of each primer set
was calculated based on the respective standard curve using the
formula: E = 10(−1/slope)−1 × 100%. Melting curve analysis
was also performed to verify the speciﬁcity of the primer pairs,
by using software ‘dissociation curve’ (Applied Biosystems). The
reaction mix consisted of 10 μL of 1x QuantiTect SYBR Green
master mix (QIAGEN) with HotStar Taq, 0.5 μl of each primer
(10 μM), the respective genomic DNA template (10 ng for bac-
teria; 1 ng for human) or prepared standard and PCR grade
water to a ﬁnal volume of 20 μL. Thermal cycling conditions
were as follows: 50◦C for 2 min, activation step at 95◦C for
15 min, followed by 40 cycles of denaturation (95 C for 15 s),
annealing (60◦C for 1 min), and elongation (72◦C for 15 s).
All samples including the non-template control and dilution
series of standards were run in triplicate. Results were ana-
lyzed using the ABI Prism 7900HT sequence detection system
(Version 2.4).
STATISTICS
Diversity indices (including Shannon–Wiener index, Inverse-
Simpson index, and rarefaction curves) were calculated on
rareﬁed 16S rRNA gene sequence data for all samples at
97% similarity using mothur and then values were for-
mally compared using Student’s t-test. In addition, equal
numbers of sequences were subsampled to assess the sig-
niﬁcance of differences between sample types using UniFrac
(phylogeny-based; Lozupone et al., 2011). Samples were assem-
bled according to disease status, inter-personal differences
and sampling site to test for the percentage of varia-
tion in samples accounted for by each group, as measured
by R2, using permutational multivariate analysis of vari-
ance (PERMANOVA; Anderson, 2001). UniFrac (weighted and
unweighted) distances calculated by mothur, along with the
“Adonis” function of the vegan package in R software (Oksa-
nen et al., 2013), were used for PERMANOVA. The obtained
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R2 values were then used to generate signiﬁcance values
(p-value) by comparison to 1000 random permutations of the
data set.
RESULTS
MAJOR SOURCES OF VARIATION IN THE NASAL MICROBIOTA
At bacterial phylum level the nasal microbiota has relatively
low diversity (Figure 1). Most samples were dominated by
members of the Actinobacteria (especially the genus Corynebac-
terium), Firmicutes (mostly Staphylococcus or Dolosigranulum),
Gammaproteobacteria (especiallyMoraxella) and, in selected cases,
Fusobacteria, or Bacteroidetes. Other phyla collectively comprised
only a small proportion of the bacteria that were present. The
sequence data summarized in Figures 1A,B reveals considerable
variation among the microbiota of different individuals and, to
a lesser extent, among different sites within a single individual.
In order to formally partition this variation, Adonis was used
to analyze the impact of disease status, inter-personal differences
and sampling site on multi-species community structure of sam-
ples. The largest proportion of explained variation within our
data was due to differences between individual patients (36.9%,
p < 0.001), followed by disease status (3.8%, p < 0.001). Vari-
ation between sites of an individual, and between the left and
right nostril, were also compared but these differences were not
signiﬁcant. It should be noted that the majority of the variation
between samples (∼59%) was unexplained. Analyses of variance
using Adonis based on weighted and unweighted UniFrac distance
revealed similar outcomes, thus only unweighted UniFrac values
are reported here. Below, each of these sources of variation is
discussed.
MICROBIOTA VARIATION AMONG DIFFERENT PATIENTS
The largest source of variation in bacterial community composi-
tion could be attributed to differences among patients (36.9%).
The microbiota varied considerably and non-predictably among
the CRS patients, with a less variable microbiota being seen
in the healthy subjects (Figure 2). Patients 3 and 4 from the
healthy cohort were smokers and exhibited reduced Actinobac-
teria and increased Firmicutes sequence abundance compared
with the other patients. However, such an obvious pattern was
not observed with smoking among CRS cohort. Among the
healthy cohort, members of the phyla Actinobacteria, Firmicutes,
and, to a lesser extent, Beta- and Gammaproteobacteria domi-
nated the communities, with these taxa represented largely by
the genus Corynebacterium and other unclassiﬁed Actinomyc-
etales, as well as Peptoniphilus, Staphylococcus, and Moraxella
(Figures 1A,B). The relative proportions of these main taxa
varied substantially among the different healthy individuals. In
contrast to their healthy counterparts, CRS patients displayed a
more variable microbiota, with no consistent pattern emerging.
CRS patients 4 and 9, for example, harbored a high propor-
tion of Actinobacteria (especially Corynebacterium), with patient
7 also containing Prevotella (from the phylum Bacteroidetes) at
some sinus sites. The gammaproteobacterium Moraxella dom-
inated the sinus microbiota of CRS patient 1, but was not
abundant in any of the other sampled CRS patients. Staphy-
lococcus was abundant in multiple CRS (as well as healthy)
patients, while Fusobacterium and Streptococcus were preva-
lent in patients 3 and 5, respectively. Unifrac (unweighted
and weighted) and Adonis analyses identiﬁed signiﬁcant differ-
ences between individuals (p < 0.001). Bacterial abundance, as
estimated by the qPCR-based quantiﬁcation of 16S rRNA gene
copy numbers, varied among both CRS and healthy subjects
(Figure 1C).
INFLUENCE OF DISEASE STATUS ON THE NASAL MICROBIOTA
Disease status (whether or not a subject had CRS), accounted
for only 3.8% of the variation observed within the bacterial
community composition data. While there was no obvious,
characteristic bacterial community “signature” associated with
CRS, the microbiota of CRS sufferers did appear to be more
variable than that of healthy subjects. Members of the genus
Corynebacterium, which were abundant amongst all healthy
subjects, only reached high abundance among CRS patients
4, 7, and 9, though they were present at lower numbers
in some of the other CRS individuals. Ordination analyses
(Figure 2) placed the bacterial communities of healthy subjects
relatively close together, whereas the CRS-associated commu-
nities varied greatly, in some cases overlapping largely with
the microbiota of healthy subjects and in other cases dis-
tinctly different. Clear subgroups of CRS microbiota were not
evident. The abundance of bacterial 16S rRNA gene copies
did not differ signiﬁcantly between CRS patients and healthy
subjects.
The Shannon–Wiener, Inverse-Simpson, and observed OTUs
(97%) diversity indices differed signiﬁcantly (p < 0.001) between
the microbial communities of the two cohorts of patients
(Figure 3). These diversity analysis tools show that CRS patients
exhibited lower bacterial diversity compared to their healthy
counterparts.
MICROBIOTA VARIATION AMONG DIFFERENT SITES WITHIN ONE
PATIENT
Bacterial community composition and inferred abundance did
not vary in a predictable manner across the six assayed sites
within one patient (Figure 1). As indicated above, the micro-
biotas of CRS patients were particularly variable, even within
some individuals. Only for patients 4, 6, and 9 were the com-
munities relatively consistent for the six sample sites, in two cases
dominated by Corynebacterium and in the third by Staphylococ-
cus. Among the other diseased individuals, the microbiota of
patient 1 was comprised almost exclusively of the gammapro-
teobacterium Moraxella, except for one nostril in which the
anterior nares also contained a considerable amount of Corynebac-
terium. In contrast, bacterial communities at the six sites among
the six healthy individuals remained fairly consistent at phylum
and genus level. The bacterial load in patient 1 was signiﬁ-
cantly greater compared with those of the other ﬁve healthy
individuals, but no obvious pattern was observed for any indi-
vidual site within the nasal cavity. Bacterial diversity (measured
with Shannon–Wiener, Inverse-Simpson, and observed OTUs-
97%) did not differ signiﬁcantly between sites for CRS and
healthy individuals. The same applied to comparisons between
nostrils.
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FIGURE 1 | 16S rRNA gene-based bacterial community composition
(A,B) and abundance (C) of nine CRS subjects and six healthy
individuals. Data representing each of six sites within the nasal cavities of
each subject are shown. The order of the samples for each subject displayed
is, from left to right: left anterior nares, right anterior nares, left inferior
turbinate, right inferior turbinate, left middle meatus, right middle meatus.
Bacterial community sequence data are displayed at phylum (A) and genus
(B) levels, with data for each taxon expressed as a proportion of sequence
reads for a given sample. 16S rRNA gene copy numbers are used as a proxy
for bacterial abundance in qPCR, with bars indicating mean ± SD. (n = 3; C).
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FIGURE 2 | Non-metric multidimensional scaling (MDS) plot displaying
16S rRNA gene-based bacterial community composition at bacterial
genus level. Subjects with CRS are signiﬁed by red symbols, with healthy
subjects in blue symbols. Each subject is represented by six different
samples, as outlined for Figure 1. Sequence data were compared among
samples using Bray–Curtis similarity.
FIGURE 3 | Box and whisker plots to compare bacterial community diversity between CRS and healthy subjects. (A) Inverse-Simpson,
(B) Shannon–Wiener, and (C) observed OTUs-97% indices were calculated for the two groups of samples. Signiﬁcant values (p-values) between the two
groups are displayed on the plots.
DISCUSSION
Although a number of molecular studies of the nasal micro-
biota have been published over the past decade, there has been
no consensus on sample collection sites, analytical methods, or
interpretation of the results obtained. Accordingly, comparison of
results from different studies is difﬁcult. Bacterial communities
are known to have distinct biogeographic patterns within their
environment (Hanson et al., 2012). However, there has been lit-
tle research to investigate such variation within the human nasal
cavities. In this study we investigated the spatial variability of the
nasal microbiota both within an individual subject and between
patients with CRS and normal subjects.
The high amount of unexplained variation observed in this
study is typical of many data sets of ecological study (Borcard et al.,
1992), where it is not feasible to measure all the environmental
variables such as biological interactions and external environmen-
tal factors. The parameters that were speciﬁcally examined in this
study accounted for only about 41% of the variability observed. In
future studies, other factors that measure host interaction (such
as cytokines) should also be considered along with the microbial
component.
Small cohort sizes are an inherent limitation of studying CRS,
as noted previously in the literature (Abreu et al., 2012; Feazel
et al., 2012; Choi et al., 2014). The requirement for patients to
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remain off antibiotics for at least 4 weeks prior to surgery, coupled
with the difﬁcult nature of obtaining the samples (via endoscopic
sinus surgery), inevitably results in small sample sizes. In addition,
acquiring samples from healthy subjects is particularly difﬁcult, as
only patients undergoing FESS are recruited for the study. The
cohort used in this study is small, but it is comparable to that in
many other published studies and was still sufﬁcient to give us
signiﬁcant results for comparisons between patients and disease
status. Intra-patient variability was examined per patient, thus we
speculate that a larger cohort would not change the outcome of
this result.
MICROBIOTA VARIATION AMONG DIFFERENT PATIENTS
This study indicates that disease status (CRS vs. healthy) accounted
for less of the observed variation than inter-patient differences.
These results are consistent with other human-associated micro-
biota studies on the gut (Turnbaugh et al., 2008), oral cavity
(Nasidze et al., 2009), and skin (Grice et al., 2009), which reported
high levels of variability among individuals. Another such study,
investigating the overall human microbiota across different body
parts of healthy subjects, also indicated that a personalized micro-
biota is relatively stable within a given individual over time
(Costello et al., 2009) and that variation in microbial composi-
tion was largely due to inter-personal differences. Other studies
on healthy- and CRS-associated nasal microbiota have also found
large variation among individuals (Feazel et al., 2012; Ramakr-
ishnan et al., 2013b). The results of this study build on upon
the emerging understanding of CRS as a heterogeneous group
of diseases that share clinical symptoms (Benninger et al., 2003;
Van Crombruggen et al., 2011). These ﬁndings have implications
for clinical treatment and prevention of CRS. It may be that
treatment optimized to the speciﬁc microbiota of the patient is
required.
It has been previously shown that smoking causes the rela-
tive proportion of Firmicutes to increase, and Actinobacteria to
decrease, in healthy (non-CRS) individuals (Ramakrishnan et al.,
2013b). The slight variations observed in the healthy cohort within
our studymight be explained by smoking, as this phenomenonwas
observed in patients 3 and 4 (both smokers) compared with the
non-smokers. However, amongst the CRS cohort only one sub-
ject was a smoker. Thus, the considerable variability in bacterial
composition between individuals of the CRS cohort still remains
largely unexplained.
EFFECT OF DISEASE STATUS ON THE NASAL MICROBIOTA
Bacterial abundance was measured in this study using 16S rRNA
gene targeted qPCR.Again, the results were highly variable and not
related to disease status. These results are consistent with the ﬁnd-
ings of others who used similar methodology (Abreu et al., 2012).
However, other studies using different techniques to that used
in this study have reported a signiﬁcantly greater bacterial load
(in particular S. aureus) in CRS patients compared with normal
controls (Foreman et al., 2009; Boase et al., 2013).
These data indicate a greater degree of variation in microbial
community structure among CRS patients compared to healthy
individuals. However, the bacterial diversity of CRS patients
was reduced. This ﬁnding has been observed in several other
inﬂammatory diseases (e.g., cystic ﬁbrosis, inﬂammatory bowel
disease; Ott et al., 2004; Guss et al., 2010). The more stable com-
munity structure of healthy individuals suggest that dysbiosis (or
imbalance) in the microbial community is linked to the occur-
rence of CRS. Microbial dysbiosis could also be due to the multiple
courses of antibiotics prescribed to CRS patients in the years prior
to surgery, which could in turn contribute to the lower bacterial
diversity (Liu et al., 2013).
Another emerging view of CRS is that it is a fundamentally host
immune system-mediated disease and requires sub-classiﬁcation
based on immunological and histological factors (Akdis et al.,
2013). Further studies are required to clarify the role of the host
immune-mediated responses in CRS and their interaction with
microbial communities.
SAMPLING WITHIN THE NASAL CAVITY
Microbial community structure did not differ signiﬁcantly
between sites or between the left and right nostrils of an indi-
vidual. Of the four parameters chosen to investigate variation
in samples, these two had the least impact. The slight varia-
tions observed in bacterial load or diversity, as seen in CRS
patients 3, 5, and 7, could be due to the heterogeneous nature
of the disease. The anterior naris is considered to be a rela-
tively dry environment, with a different epithelium type compared
to the other two sites analyzed in this study. The middle mea-
tus and inferior turbinates are deeper in the nasal cavity and
covered in a mucus blanket that is secreted by goblet cells.
This provides an ideal environment for bioﬁlm development, as
observed previously in CRS patients (Cryer et al., 2004; Fore-
man et al., 2012). Based on the ﬁndings of Yan et al. (2013) and
Bassis et al. (2014) and the different microenvironments of the
study sites, we might have expected the nasal microbiota of the
chosen sites to differ. However, our study detected no signiﬁ-
cant differences in bacterial diversity, composition or abundance
between the different sites of either CRS or healthy individuals.
Furthermore, different sides of the nasal cavity contained essen-
tially the same microbiota, another important ﬁnding from this
study. This study is the ﬁrst of its kind for CRS and should be
taken into consideration when designing future research in this
area.
CONCLUSION
This study provides some insight into the differences among
microbial communities in the human nasal ecosystem. Some-
what unexpectedly, we observed that between-patient differences
explained more of the variation in the nasal microbiota than did
disease status or different sampling sites within the nasal cavities.
An improved understanding of the causes of variation in bacterial
composition, diversity, and abundance in the nasal cavity of CRS
patients may help tailor improved clinical treatments in the future.
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